Financhill
Back

Summit Therapeutics Stock Predictions

Summit Therapeutics Stock Forecast

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 68.6% based on the past 10 years of stock performance.
  • Summit Therapeutics has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
  • Is Summit Therapeutics Stock Undervalued?
    The current Summit Therapeutics [SMMT] share price is $19.73. The Score for SMMT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Summit Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 68.6% based on the past 10 years of stock performance.

Summit Therapeutics Stock Rating

Sell
30
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics overpriced?

  • Summit Therapeutics has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Summit Therapeutics Stock Price History

Is SMMT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
smmttx.com

52-Week Data

52-Week High:
36.91
52-Week Low:
6.78

Prediction Charts

Market Cap:
14.7B
Price in USD:
19.73
Volume:
3.4M
Beta:
-0.25

Technical Analysis

SMA50:
23.28
SMA100:
21.78
SMA200:
20.35
52-Wk Change:
145.4%

Stock Predictions

  • Is Summit Therapeutics stock public?
    Yes, Summit Therapeutics is a publicly traded company.
  • What is the Summit Therapeutics stock quote today?
    The Summit Therapeutics stock price is 19.73 USD today.
  • How to buy Summit Therapeutics stock online?
    You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-16 23.14 23.87 23.94 23.04
May-19 23.80 24.01 24.02 22.85
May-20 23.64 24.39 24.45 23.45
May-21 24.13 25.41 26.85 23.88
May-22 25.62 25.77 26.44 25.05
May-23 25.48 25.85 26.17 25.12
May-27 26.29 25.64 26.90 25.54
May-28 25.66 26.04 26.35 25.07
May-29 26.38 26.21 27.09 26.03
May-30 21.20 18.22 21.63 18.01
Jun-2 18.81 17.73 18.81 16.03
Jun-3 18.40 20.62 20.67 17.32
Jun-4 20.10 19.56 20.50 19.20
Jun-5 19.58 19.73 20.24 19.20

Summit Therapeutics Earnings

Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Summit Therapeutics Forecast Revenue Growth

Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.

* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.